Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+4.37%)
As of: Nov 9, 2026 · 9:54 AM EST

Kala Bio (KALA) Revenue (2019 - 2022)

Updated

Analysis

Kala Bio (KALA) Revenue (2019 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,231.10 Bn 1,204.71 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 669.11 Bn 588.97 Bn 17.30 Bn 25.40 Bn
3 AbbVie 513.20 Bn 481.21 Bn 13.12 Bn 17.40 Bn
4 Merck 361.72 Bn 324.66 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 313.59 Bn 286.83 Bn - -
6 Astrazeneca 290.36 Bn 264.25 Bn 13.26 Bn 15.07 Bn
7 Amgen 246.51 Bn 198.16 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 206.71 Bn 181.82 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.30 Bn 112.66 Bn 12.56 Bn 16.58 Bn
10 Kala Bio 2.48 Mn -42.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 420,000.00
Jun 30, 2022 2.10 Mn
Mar 31, 2022 1.37 Mn
Dec 31, 2021 1.86 Mn
Sep 30, 2021 3.07 Mn
Jun 30, 2021 3.05 Mn
Mar 31, 2021 3.27 Mn
Dec 31, 2020 2.24 Mn
Sep 30, 2020 2.22 Mn
Jun 30, 2020 833,000.00
Mar 31, 2020 1.07 Mn
Dec 31, 2019 1.18 Mn
Sep 30, 2019 1.45 Mn
Jun 30, 2019 2.06 Mn
Mar 31, 2019 1.39 Mn
API Access

Kala Bio Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KALA&period=max&api_key=YOUR_API_KEY